Items of Interest
UPDATE: In December 2016 the FDA removed its previous Boxed Warning concerning mental health side effects from both Chantix and Zyban labels. Patients should still be monitored from their health care prescriber. FDA reports clearly that taking medication to stop smoking outweighs possible side effects.
Baltimore City's Health Department has launched the “311 for tobacco complaints” program, encouraging city residents to call 311 if they witness stores selling to minors, selling individual cigarettes (“loosies”), or placing nicotine product placements behind counters.
Community-based/Medical-based prevention strategies offer a promising solution to reducing and preventing the initiation of smoking and tobacco use. Community/Medical based prevention interventions can focus on altering tobacco use behavior, promoting tobacco use change within the community, and/or passing and enforcing anti-tobacco legislation.
DHMH has released the 2016-2020 Maryland Comprehensive Cancer Control Plan! View a copy HERE. Tobacco Use can be found in the Primary Prevention of Cancer section, pg 24.
University of MD School of Public Health is enrolling female smokers ages 18-75 in a clinical research study to evaluate an investigational medication to stop smoking. Qualified participants receive study medication, smoking cessation counseling, and are compensated for their time. Click here for mo
(released 12/2015) is a joint effort among national tobacco prevention and cessation organizations. Access this annual report here.